Advertisement
Screener

SpyGlass Pharma, Inc. (SGP) Graph

SGP Revenue Flow

A current filed revenue breakdown could not be established from the retained filing evidence.

  • 2026-06-30: Research and development $10.94M; Operating expenses $21.97M; Income tax $0.00; Net income -$19.86M.
  • 2026-03-31: Research and development $8.54M; Operating expenses $15.41M; Income tax $0.00; Net income -$13.82M.
  • 2025-06-30: Research and development $7.33M; Operating expenses $9.30M; Income tax $0.00; Net income -$8.68M.
  • 2025-03-31: Research and development $6.05M; Operating expenses $7.42M; Income tax $0.00; Net income -$8.82M.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endResearch and developmentOperating expensesIncome taxNet income
2026-06-30$10.94M$21.97M$0.00-$19.86M
2026-03-31$8.54M$15.41M$0.00-$13.82M
2025-06-30$7.33M$9.30M$0.00-$8.68M
2025-03-31$6.05M$7.42M$0.00-$8.82M

Revenue and expense 6 month

Period endResearch and developmentOperating expensesIncome taxNet income
2026-06-30$19.48M$37.38M$0.00-$33.68M
2025-06-30$13.38M$16.72M$0.00-$17.50M

Revenue and expense 12 month

Period endResearch and developmentOperating expensesIncome taxNet income
2025-12-31$29.18M$41.45M$0.00-$39.87M
2024-12-31$19.98M$27.06M$0.00-$29.16M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
IRADIMED CORP (IRMD)United States$1.089B52.92
ARTIVION, INC. (AORT)United States$1.123B-345.09
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B